Showing results (1-10 of 14) with videos related to

Sort By:
Pageof 2
Inflammation|June 1, 2015
Chitotriosidase Expression during Monocyte-Derived Dendritic Cells Differentiation and MaturationMichelino Di Rosa, Daniele Tibullo, Daniela Cambria, et al.
Frontiers in Oncology|January 7, 2021
Mitochondrial Bioenergetics at the Onset of Drug Resistance in Hematological Malignancies: An OverviewAlessandro Barbato, Grazia Scandura, Fabrizio Puglisi, et al.
Frontiers in Oncology|March 3, 2023
Ruxolitinib treatment in myelofibrosis and polycythemia vera causes suboptimal humoral immune response following standard and booster vaccination with BNT162b2 mRNA COVID-19 vaccineGiuseppe A Palumbo, Daniela Cambria, Enrico La Spina, et al.
Vaccines|February 26, 2025
Immune Response and Breakthrough Infection Risk After SARS-CoV-2 Vaccines in Patients with Hemoglobinopathy: A Single Center ExperienceAndrea Duminuco, Anna Bulla, Rosamaria Rosso, et al.
Frontiers in Oncology|April 17, 2023
Clinical outcome of SARS-CoV-2 infections occurring in multiple myeloma patients after vaccination and prophylaxis with tixagevimab/cilgavimabAndrea Duminuco, Alessandra Romano, Dario Leotta, et al.
Frontiers in Oncology|March 13, 2023
Mesenchymal stromal cells in tumor microenvironment remodeling of BCR-ABL negative myeloproliferative diseasesEnrico La Spina, Sebastiano Giallongo, Cesarina Giallongo, et al.
Biomarker Research|February 10, 2025
BNT162b2 mRNA vaccination affects the gut microbiome composition of patients with follicular lymphoma and chronic lymphocytic leukemiaAnnalisa Chiarenza, Gaia Vertillo Aluisio, Nunziatina Laura Parrinello, et al.
Cancer|September 2, 2023
Efficacy and safety of tixagevimab-cilgavimab versus SARS-CoV-2 breakthrough infection in the hematological conditionsAndrea Duminuco, Antonella Nardo, Alessandra Orofino, et al.
Life (Basel, Switzerland)|February 25, 2023
IGFBP-6 Alters Mesenchymal Stromal Cell Phenotype Driving Dasatinib Resistance in Chronic Myeloid LeukemiaDaniela Cambria, Lucia Longhitano, Enrico La Spina, et al.
Cancers|July 26, 2020
Inhibition of TLR4 Signaling Affects Mitochondrial Fitness and Overcomes Bortezomib Resistance in Myeloma Plasma CellsCesarina Giallongo, Daniele Tibullo, Fabrizio Puglisi, et al.
Pageof 2